[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353805-105":59,"doc-detail-353805-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multidimensional-immune-profiling-uncovers-biphasic-peripheral-t-cell-dynamics-after-chemoradiation-in-patients-with-locally-advanced-head-and-neck-cancer","Multidimensional immune profiling uncovers biphasic peripheral T-cell dynamics after chemoradiation in patients with locally advanced head and neck cancer","","Cisplatin-based concurrent chemoradiation remains standard for locally advanced head and neck squamous cell carcinoma, but recurrence rates stay high and prior combinations with immune checkpoint inhibitors have not improved outcomes. Longitudinal multidimensional profiling of peripheral immunity at baseline, one month, and three months after platinum-based CRT shows a transient early reduction in tumor-reactive Th1 responses, followed by marked expansion by CRT-3M. Gene programs for T-cell activation, polarization, and exhaustion display a biphasic pattern with delayed upregulation at CRT-3M. Integrated analyses link early T-cell decline to immunosuppressive cell increases, exhaustion, and protumoral cytokines, whereas robust tumor-reactive expansion dominates later.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multidimensional-immune-profiling-uncovers-biphasic-peripheral-t-cell-dynamics-after-chemoradiation-in-patients-with-locally-advanced-head-and-neck-cancer/353805/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multidimensional-immune-profiling-uncovers-biphasic-peripheral-t-cell-dynamics-after-chemoradiation-in-patients-with-locally-advanced-head-and-neck-cancer/353805.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What treatment is studied in locally advanced head and neck squamous cell carcinoma?","Question",{"text":112,"@type":113},"The study focuses on cisplatin-based concurrent chemoradiation (CRT) and its immunologic effects over time.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What peripheral T-cell response pattern does CRT induce?",{"text":117,"@type":113},"CRT causes an early transient reduction in tumor-reactive Th1 responses at CRT-1M, followed by marked expansion by CRT-3M, with a biphasic gene expression pattern related to T-cell activation and exhaustion.",{"name":119,"@type":110,"acceptedAnswer":120},"Why might combining immune checkpoint inhibitors with CRT have failed in earlier trials?",{"text":121,"@type":113},"The text highlights CRT-driven immunosuppression factors such as lymphopenia and myeloid reprogramming, along with treatment-related inflammation that may impair adaptive immune responses needed for ICI activity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353805,1790184561,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","ONCOIMMUNOLOGY  \n2026, VOL. 15, NO. 1, 2635806  \n[https://doi.org/10.1080/2162402X.2026.2635806](https://doi.org/10.1080/2162402X.2026.2635806)  \nRESEARCH ARTICLE     \nMultidimensional immune profiling uncovers biphasic peripheral T-cell dynamics after chemoradiation in patients with locally advanced head and neck cancer  \nBenoît Lecoestera, 1, Yaoyao Xiea, b, 1, Xushan Sunc, Adeline Renaudina, Babacar Ndaoa, Laura Boullerota, Marine Malfroya, Rudy Arniera, Cyril Boissond, Caroline Laheurtea, Aurelia Meurissed, Cédric Chevaliere, Noémie Vulquine, David Thibouwe, Salim Benhmidaf, Mandy Pernotf, Dewi Vernereyd, Céline Mirjoletg, Junming Guob, Jihane Boustania,f, 1 and Olivier Adotevia, 1  \naUniversité Marie et Louis Pasteur, EFS, INSERM, UMR RIGHT, Besançon, France; bDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo, China; cDepartment of Radiation Oncology, University Hospital of Besançon and Nord Franche-Comté Hospital, Montbéliard, France; dDepartment of Medical Oncology, Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France; eDepartment of Radiation Oncology, Unicancer-Georges-Francois Leclerc Cancer Center, Dijon, France; fDepartment of Radiation Oncology, University Hospital of Besançon, Besançon, France; gUniversité Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, X-RAIN Unit, IMATHERA, UMS INSERM 58 and CTM, UMR INSERM 1231, TIRECs Team, Dijon, France  \nABSTRACT  \nCisplatin-based concurrent chemoradiation (CRT) remains the standard treatment for locally advanced head and neck squamous cell carcinoma (LA-HNSCC), yet recurrence rates remain high. Attempts to combine immune checkpoint inhibitors with CRT have not improved outcomes, underscoring the need to better understand CRT-driven immunologic dynamics. Here, we performed longitudinal, multidimensional profiling of peripheral immunity in patients with LA-HNSCC at baseline (BSL), one month (CRT- 1M), and three months (CRT-3M) after platinum-based CRT. CRT induced a transient reduction in tumor-reactive Th1 responses at CRT-1M, followed by marked expansion by CRT-3M. Consistently, genes involved in T-cell activation, polarization, and exhaustion exhibited a biphasic pattern with delayed upregulation at CRT-3M. Transcriptomic analyses of blood lymphocytes revealed an early shift from B-cell– to T-cell–mediated pathways over time during CRT. Integrated analyses including immunosuppressive cells and soluble mediators showed that the early decline in tumor-reactive T cells coincided with increased immunosuppressive cells, T-cell exhaustion, and elevated protumoral cytokines such as IL-8, IL-1β, and IL-10 . In contrast, robust expansion of tumor-reactive T cells dominated the peripheral immune landscape at CRT-3M. Together, these data reveal the dynamic remodeling of peripheral immunity following platinum-based CRT and identify a delayed peripheral immune activation phase that may represent an optimal window for combining CRT with immune checkpoint blockade.  \nARTICLE HISTORY  \nReceived 20 December 2025 Revised 5 February 2026 Accepted 12 February 2026  \nKEYWORDS  \nChemoradiation; systemic immunity; tumor-specific T cells; head and necksquamous cell carcinoma  \nIntroduction  \nHead and neck squamous cell carcinoma (HNSCC), accounting for approximately 90% of all head and neck cancer (HNC) cases, represents a major global health burden, with nearly one million new cases and half a million deaths annually. 1 Excessive tobacco use, alcohol consumption, and human papillomavirus (HPV) infection, primarily HPV-16, followed by HPV-18, are generally associated with the development of HNSCC.2 Most HNSCC patients are diagnosed with locally advanced stage. Concurrent chemoradiation (CRT) is the standard of care for locally advanced HNSCC (LA-HNSCC) . High-dose cisplatin chemotherapy (CT) administered every three weeks, combined with concurrent radiot","cbCaimb7FBaCqYAj","https://ap.wps.com/l/cbCaimb7FBaCqYAj","pdf",5653708,"English","# Abstract\n# Introduction","[{\"question\":\"What treatment is studied in locally advanced head and neck squamous cell carcinoma?\",\"answer\":\"The study focuses on cisplatin-based concurrent chemoradiation (CRT) and its immunologic effects over time.\"},{\"question\":\"What peripheral T-cell response pattern does CRT induce?\",\"answer\":\"CRT causes an early transient reduction in tumor-reactive Th1 responses at CRT-1M, followed by marked expansion by CRT-3M, with a biphasic gene expression pattern related to T-cell activation and exhaustion.\"},{\"question\":\"Why might combining immune checkpoint inhibitors with CRT have failed in earlier trials?\",\"answer\":\"The text highlights CRT-driven immunosuppression factors such as lymphopenia and myeloid reprogramming, along with treatment-related inflammation that may impair adaptive immune responses needed for ICI activity.\"}]","Multidimensional immune profiling uncovers biphasic peripheral T-cell dynamics after chemoradiation in patients with locally advanced head and neck cancer | PDF",1790107347,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6a33313cd1f3499301a5c0939ff1277.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5735d0cc564ddfc9de527f158b13290a.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95d8266251664140622a013ab4695490.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d73d2819ee3df5b1f54e33edb14284e.webp",980,1306]